Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Taxotere and Oxaliplatin in Head and Neck Squamous Cell Carcinoma
NCT00184028Phase 2Terminated
- Sponsor
- University of Southern California
- Start
- Sep 2004
- Primary completion
- Jul 2009
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of docetaxel, oxaliplatin in squamous cell carcinoma of the head and neck (HNSCC), sponsored by University of Southern California. Started Sep 2004; status: terminated.
02
Drugs
docetaxeloxaliplatin
03
Conditions
squamous cell carcinoma of the head and neck (HNSCC)
Beyond the preview
Go deeper on NCT00184028.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00184028.